Preparation and Characterization of a Dry Powder Inhaler Composed of PLGA Large Porous Particles Encapsulating Gentamicin Sulfate
Purpose: Direct delivery of aminoglycosides to the lungs was under extensive evaluations during the last decades. Because of large particle size, low density and porous structure, large porous particles (LPPs) are versatile carriers for this purpose. In this study, poly (lactic-co-glycolic acid) (PL...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Tabriz University of Medical Sciences
2019-06-01
|
Series: | Advanced Pharmaceutical Bulletin |
Subjects: | |
Online Access: | https://apb.tbzmed.ac.ir/PDF/apb-25397 |
id |
doaj-d18853ab8435477682519971fe7b12c3 |
---|---|
record_format |
Article |
spelling |
doaj-d18853ab8435477682519971fe7b12c32020-11-24T20:43:21ZengTabriz University of Medical Sciences Advanced Pharmaceutical Bulletin2228-58812251-73082019-06-019225526110.15171/apb.2019.029apb-25397Preparation and Characterization of a Dry Powder Inhaler Composed of PLGA Large Porous Particles Encapsulating Gentamicin SulfateFarideh Shiehzadeh0Mohsen Tafaghodi1Majid Laal-Dehghani2Faezeh Mashhoori3Bibi Sedigheh Fazly Bazzaz4Mohsen Imenshahidi5School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.Purpose: Direct delivery of aminoglycosides to the lungs was under extensive evaluations during the last decades. Because of large particle size, low density and porous structure, large porous particles (LPPs) are versatile carriers for this purpose. In this study, poly (lactic-co-glycolic acid) (PLGA) LPPs encapsulating gentamicin sulfate were prepared and in vitro characteristics of their freeze-dried powder as a dry powder inhaler (DPI) were evaluated. Methods: To prepare PLGA LPPs, a double emulsification-solvent evaporation method was optimized and gentamicin sulfate was post-loaded in the LPPs. In vitro characteristics including morphological features, thermal behavior, aerodynamic profile and cumulative drug release were evaluated by the scanning electron microscope (SEM), differential scanning calorimetry (DSC), next-generation cascade impactor (NGI) and Franz diffusion cell respectively. Results: The obtained results revealed that the preparation method was capable to produce spherical large homogenous highly porous particles. 94% of gentamicin sulfate released from LPPs up to 30 minutes. Mass median aerodynamic diameter (MMAD) and fine particle fraction (FPF) were 4.9 µm and 39% respectively. Conclusion: In this study, dry powder formulation composed of PLGA LPPs encapsulating gentamicin sulfate showed a promising in vitro behavior as a pulmonary delivery carrier. Improvements on the aerodynamic behavior and in vivo evaluations recommended for further developments.https://apb.tbzmed.ac.ir/PDF/apb-25397AminoglycosidesDrug delivery systemsDry powder inhalersGentamicin sulfateLarge porous particlesLung |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Farideh Shiehzadeh Mohsen Tafaghodi Majid Laal-Dehghani Faezeh Mashhoori Bibi Sedigheh Fazly Bazzaz Mohsen Imenshahidi |
spellingShingle |
Farideh Shiehzadeh Mohsen Tafaghodi Majid Laal-Dehghani Faezeh Mashhoori Bibi Sedigheh Fazly Bazzaz Mohsen Imenshahidi Preparation and Characterization of a Dry Powder Inhaler Composed of PLGA Large Porous Particles Encapsulating Gentamicin Sulfate Advanced Pharmaceutical Bulletin Aminoglycosides Drug delivery systems Dry powder inhalers Gentamicin sulfate Large porous particles Lung |
author_facet |
Farideh Shiehzadeh Mohsen Tafaghodi Majid Laal-Dehghani Faezeh Mashhoori Bibi Sedigheh Fazly Bazzaz Mohsen Imenshahidi |
author_sort |
Farideh Shiehzadeh |
title |
Preparation and Characterization of a Dry Powder Inhaler Composed of PLGA Large Porous Particles Encapsulating Gentamicin Sulfate |
title_short |
Preparation and Characterization of a Dry Powder Inhaler Composed of PLGA Large Porous Particles Encapsulating Gentamicin Sulfate |
title_full |
Preparation and Characterization of a Dry Powder Inhaler Composed of PLGA Large Porous Particles Encapsulating Gentamicin Sulfate |
title_fullStr |
Preparation and Characterization of a Dry Powder Inhaler Composed of PLGA Large Porous Particles Encapsulating Gentamicin Sulfate |
title_full_unstemmed |
Preparation and Characterization of a Dry Powder Inhaler Composed of PLGA Large Porous Particles Encapsulating Gentamicin Sulfate |
title_sort |
preparation and characterization of a dry powder inhaler composed of plga large porous particles encapsulating gentamicin sulfate |
publisher |
Tabriz University of Medical Sciences |
series |
Advanced Pharmaceutical Bulletin |
issn |
2228-5881 2251-7308 |
publishDate |
2019-06-01 |
description |
Purpose: Direct delivery of aminoglycosides to the lungs was under extensive evaluations during the last decades. Because of large particle size, low density and porous structure, large porous particles (LPPs) are versatile carriers for this purpose. In this study, poly (lactic-co-glycolic acid) (PLGA) LPPs encapsulating gentamicin sulfate were prepared and in vitro characteristics of their freeze-dried powder as a dry powder inhaler (DPI) were evaluated. Methods: To prepare PLGA LPPs, a double emulsification-solvent evaporation method was optimized and gentamicin sulfate was post-loaded in the LPPs. In vitro characteristics including morphological features, thermal behavior, aerodynamic profile and cumulative drug release were evaluated by the scanning electron microscope (SEM), differential scanning calorimetry (DSC), next-generation cascade impactor (NGI) and Franz diffusion cell respectively. Results: The obtained results revealed that the preparation method was capable to produce spherical large homogenous highly porous particles. 94% of gentamicin sulfate released from LPPs up to 30 minutes. Mass median aerodynamic diameter (MMAD) and fine particle fraction (FPF) were 4.9 µm and 39% respectively. Conclusion: In this study, dry powder formulation composed of PLGA LPPs encapsulating gentamicin sulfate showed a promising in vitro behavior as a pulmonary delivery carrier. Improvements on the aerodynamic behavior and in vivo evaluations recommended for further developments. |
topic |
Aminoglycosides Drug delivery systems Dry powder inhalers Gentamicin sulfate Large porous particles Lung |
url |
https://apb.tbzmed.ac.ir/PDF/apb-25397 |
work_keys_str_mv |
AT faridehshiehzadeh preparationandcharacterizationofadrypowderinhalercomposedofplgalargeporousparticlesencapsulatinggentamicinsulfate AT mohsentafaghodi preparationandcharacterizationofadrypowderinhalercomposedofplgalargeporousparticlesencapsulatinggentamicinsulfate AT majidlaaldehghani preparationandcharacterizationofadrypowderinhalercomposedofplgalargeporousparticlesencapsulatinggentamicinsulfate AT faezehmashhoori preparationandcharacterizationofadrypowderinhalercomposedofplgalargeporousparticlesencapsulatinggentamicinsulfate AT bibisedighehfazlybazzaz preparationandcharacterizationofadrypowderinhalercomposedofplgalargeporousparticlesencapsulatinggentamicinsulfate AT mohsenimenshahidi preparationandcharacterizationofadrypowderinhalercomposedofplgalargeporousparticlesencapsulatinggentamicinsulfate |
_version_ |
1716820141757431808 |